Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Colombo

Showing results (821-830 of 1,114) with videos related to

Pageof 112
Sort By:
American Heart Journal|December 1, 2012
Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control studyAzeem Latib, Francesco Maisano, Letizia Bertoldi, et al.
The Journal of Invasive Cardiology|May 16, 2018
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 StudyUmberto Barbero, Rahim Kanji, Enrico Cerrato, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trialRobbert J de Winter, Azfar Zaman, Hironori Hara, et al.
The American Journal of Cardiology|July 9, 2016
Effect of Transcatheter Mitral Annuloplasty With the Cardioband Device on 3-Dimensional Geometry of the Mitral AnnulusMani Arsalan, Eustachio Agricola, Ottavio Alfieri, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery diseasePatrick W Serruys, Joost Daemen, Marie-Claude Morice, et al.
Circulation|June 15, 2013
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX scoreVasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.
BMJ (Clinical Research Ed.)|November 5, 2016
Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trialsGiuseppe Gargiulo, Stephan Windecker, Bruno R da Costa, et al.
International Journal of Cardiology|November 7, 2016
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter studyGuilherme F Attizzani, Yohei Ohno, Azeem Latib, et al.
The American Journal of Cardiology|February 27, 2017
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve ImplantationAntonio Mangieri, Richard J Jabbour, Claudio Montalto, et al.
Circulation|April 8, 2015
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upJavaid Iqbal, Yao-Jun Zhang, David R Holmes, et al.
Pageof 112

Showing results (821-830 of 1,114) with videos related to

Sort By:
Pageof 112
American Heart Journal|December 1, 2012
Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control studyAzeem Latib, Francesco Maisano, Letizia Bertoldi, et al.
The Journal of Invasive Cardiology|May 16, 2018
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 StudyUmberto Barbero, Rahim Kanji, Enrico Cerrato, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trialRobbert J de Winter, Azfar Zaman, Hironori Hara, et al.
The American Journal of Cardiology|July 9, 2016
Effect of Transcatheter Mitral Annuloplasty With the Cardioband Device on 3-Dimensional Geometry of the Mitral AnnulusMani Arsalan, Eustachio Agricola, Ottavio Alfieri, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery diseasePatrick W Serruys, Joost Daemen, Marie-Claude Morice, et al.
Circulation|June 15, 2013
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX scoreVasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.
BMJ (Clinical Research Ed.)|November 5, 2016
Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trialsGiuseppe Gargiulo, Stephan Windecker, Bruno R da Costa, et al.
International Journal of Cardiology|November 7, 2016
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter studyGuilherme F Attizzani, Yohei Ohno, Azeem Latib, et al.
The American Journal of Cardiology|February 27, 2017
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve ImplantationAntonio Mangieri, Richard J Jabbour, Claudio Montalto, et al.
Circulation|April 8, 2015
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upJavaid Iqbal, Yao-Jun Zhang, David R Holmes, et al.
Pageof 112